1. Home
  2. BHB vs TBPH Comparison

BHB vs TBPH Comparison

Compare BHB & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHB
  • TBPH
  • Stock Information
  • Founded
  • BHB 1887
  • TBPH 2013
  • Country
  • BHB United States
  • TBPH United States
  • Employees
  • BHB N/A
  • TBPH N/A
  • Industry
  • BHB Major Banks
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHB Finance
  • TBPH Health Care
  • Exchange
  • BHB Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • BHB 465.0M
  • TBPH 536.5M
  • IPO Year
  • BHB 1997
  • TBPH N/A
  • Fundamental
  • Price
  • BHB $29.07
  • TBPH $11.34
  • Analyst Decision
  • BHB Hold
  • TBPH Strong Buy
  • Analyst Count
  • BHB 2
  • TBPH 5
  • Target Price
  • BHB $33.50
  • TBPH $16.60
  • AVG Volume (30 Days)
  • BHB 44.9K
  • TBPH 161.5K
  • Earning Date
  • BHB 07-22-2025
  • TBPH 08-12-2025
  • Dividend Yield
  • BHB 4.47%
  • TBPH N/A
  • EPS Growth
  • BHB N/A
  • TBPH N/A
  • EPS
  • BHB 2.57
  • TBPH N/A
  • Revenue
  • BHB $147,013,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • BHB $18.44
  • TBPH $51.74
  • Revenue Next Year
  • BHB $14.54
  • TBPH N/A
  • P/E Ratio
  • BHB $11.15
  • TBPH N/A
  • Revenue Growth
  • BHB 0.37
  • TBPH 6.11
  • 52 Week Low
  • BHB $26.43
  • TBPH $7.44
  • 52 Week High
  • BHB $38.47
  • TBPH $11.88
  • Technical
  • Relative Strength Index (RSI)
  • BHB 40.02
  • TBPH 44.09
  • Support Level
  • BHB $28.06
  • TBPH $10.90
  • Resistance Level
  • BHB $31.18
  • TBPH $11.26
  • Average True Range (ATR)
  • BHB 0.84
  • TBPH 0.25
  • MACD
  • BHB -0.33
  • TBPH -0.09
  • Stochastic Oscillator
  • BHB 22.80
  • TBPH 2.38

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: